Ono Pharmaceutical (Japan) (Q334345): Difference between revisions

From geokb

Latest revision as of 15:22, 10 September 2024

company organization in Osaka, Japan

小野薬品工業株式会社

Language	Label	Description	Also known as
English	Ono Pharmaceutical (Japan)	company organization in Osaka, Japan	小野薬品工業株式会社

Statements

0 references

addresses subject

Cyclooxygenase-2 Inhibitors in Inflammation and Cancer

189

1 reference

https://openalex.org/I4210112155

Cancer Immunotherapy

90

1 reference

https://openalex.org/I4210112155

79

1 reference

https://openalex.org/I4210112155

Metabolism and Function of Arachidonic Acid Derivatives

60

1 reference

https://openalex.org/I4210112155

Structure and Function of G Protein-Coupled Receptors

53

1 reference

https://openalex.org/I4210112155

Bisphosphonates in Cancer Treatment and Bone Health

51

1 reference

https://openalex.org/I4210112155

47

1 reference

https://openalex.org/I4210112155

Peptide Synthesis and Drug Discovery

44

1 reference

https://openalex.org/I4210112155

Molecular Mechanisms of Osteoclast Differentiation and Bone Remodeling

42

1 reference

https://openalex.org/I4210112155

Mechanisms of Multidrug Resistance in Cancer

42

1 reference

https://openalex.org/I4210112155

Role of Nitric Oxide in Health and Disease

39

1 reference

https://openalex.org/I4210112155

Mechanisms of Estrogen Receptor Signaling

37

1 reference

https://openalex.org/I4210112155

Natural Killer Cells in Immunity

37

1 reference

https://openalex.org/I4210112155

Genomic Aberrations and Treatment of Chronic Lymphocytic Leukemia

36

1 reference

https://openalex.org/I4210112155

Advancements in Lung Cancer Research

35

1 reference

https://openalex.org/I4210112155

Drug Metabolism and Pharmacogenomics

33

1 reference

https://openalex.org/I4210112155

Molecular Mechanisms of Synaptic Plasticity and Neurological Disorders

33

1 reference

https://openalex.org/I4210112155

Sphingolipid Signalling and Metabolism in Health and Disease

31

1 reference

https://openalex.org/I4210112155

Chimeric Antigen Receptor T Cell Therapy

31

1 reference

https://openalex.org/I4210112155

Lymphoid Neoplasms

31

1 reference

https://openalex.org/I4210112155

Role of Fibroblast Activation in Cancer Progression

29

1 reference

https://openalex.org/I4210112155

Drug Delivery Systems

27

1 reference

https://openalex.org/I4210112155

Synthesis and Biological Activities of Quinoxaline Derivatives

27

1 reference

https://openalex.org/I4210112155

Innate Immune Recognition and Signaling Pathways

26

1 reference

https://openalex.org/I4210112155

Synthesis and Applications of ß-Lactams

24

1 reference

https://openalex.org/I4210112155

coordinate location

34°41'37"N, 135°30'8"E

1 reference

https://openalex.org/I4210112155

1 reference

https://openalex.org/I4210112155

official website

https://www.ono.co.jp/eng/

1 reference

https://openalex.org/I4210112155

0 references

Research Organization Registry ID

0 references

Retrieved from "https://geokb.wikibase.cloud/w/index.php?title=Item:Q334345&oldid=1270753"